Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01267
|
|||||
Drug Name |
Asimadoline
|
|||||
Synonyms |
Asimadoline [INN]; EMD 61753; N-[(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methyl-2,2-diphenylacetamide
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Irritable bowel syndrome [ICD11: DD91.0] | Phase 3 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C27H30N2O2
|
|||||
Canonical SMILES |
CN(C(CN1CCC(C1)O)C2=CC=CC=C2)C(=O)C(C3=CC=CC=C3)C4=CC=CC=C4
|
|||||
InChI |
InChI=1S/C27H30N2O2/c1-28(25(21-11-5-2-6-12-21)20-29-18-17-24(30)19-29)27(31)26(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,24-26,30H,17-20H2,1H3/t24-,25+/m0/s1
|
|||||
InChIKey |
JHLHNYVMZCADTC-LOSJGSFVSA-N
|
|||||
CAS Number |
CAS 153205-46-0
|
|||||
Pharmaceutical Properties | Molecular Weight | 414.5 | Topological Polar Surface Area | 43.8 | ||
Heavy Atom Count | 31 | Rotatable Bond Count | 7 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
XLogP |
4.1
|
|||||
PubChem CID | ||||||
PubChem SID | ||||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
References | ||||||
1 | Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313. | |||||
2 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.